An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model.
Jennis, Matthew; Kung, Che-Pei; Basu, Subhasree; Budina-Kolomets, Anna; Leu, Julia I-Ju; Khaku, Sakina; Scott, Jeremy P; Cai, Kathy Q; Campbell, Michelle R; Porter, Devin K; Wang, Xuting; Bell, Douglas A; Li, Xiaoxian; Garlick, David S; Liu, Qin; Hollstein, Monica; George, Donna L; Murphy, Maureen E.
; 30(8): 918-30, 2016 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-27034505
Endogenous DNA Damage as a Source of Genomic Instability in Cancer.
Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.
Phase Separation, Protein Disorder, and Enhancer Function.
Transcriptional Control of Dendritic Cell Development.
Explaining the biological activity of transactivation-deficient p53 variants.
A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo.
Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.
Super-Transactivation TP53 Variant in the Germline of a Family with Li-Fraumeni Syndrome.
The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.
Murine Double Minute-2 Prevents p53-Overactivation-Related Cell Death (Podoptosis) of Podocytes.